StockWatch
·

JNK India Ltd Q2 FY27 Results

JNKINDIAQ2 FY27 Results
Filing
Result:Steady· Market: Crashed

Outlook: Cautiously Optimistic · Guidance: Maintained

MetricValue (₹ Cr)Q1 FY27Q2 FY26
Revenue184.032.3%3.2%
Total Income192.603.5%4.5%
Expenditure175.152.2%5.3%
PBT17.4519.2%2.0%
Net Profit13.2837.9%1.9%
OPM9.39%0.55pp0.14pp
NPM6.89%1.72pp0.18pp
EPS2.3615.1%2.5%
View full financials

Revenue (+3.2%) and adjusted PAT (+2%) growth are both low-single-digit with margins roughly flat (OPM 9.39% vs 9.25%, NPM 6.89% vs 7.07%), an in-line, unremarkable quarter for an industrials name.

JNK INDIA LTD · QQ2 FY-2027 · THE CALL

Revenue beats guidance, but margins miss; H2 execution critical

The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.

13 Nov 2026 · 6 min read
Verdict

Hold

confidence 6/10

Credibility

Grade B

H1 beat revenue guidance, but EBITDA margins fell 200-300 bps below range. Q2 execution miss acknowledged.

Short-term outlook

Cautiously Optimistic

next 1–2 quarters

Long-term outlook

Optimistic

multi-year

JNK beat H1 revenue guidance (30.4% vs 20-25%) but missed margin targets (H1 EBITDA 10.6% vs 12-14%). Q2 suffered from execution delays (₹30-40 Cr deferred), raising H2 pressure. Large order wins (₹500 Cr Nigeria, ₹830 Cr domestic flares) provide visibility, but pipeline conversion and margin recovery remain key risks. Management maintains FY27 guidance but faces execution credibility test in Q3-Q4.

₹184 Cr

Revenue · +3.2% YoY

₹13.3 Cr

Reported PAT · +2% YoY

Compressing

Margins · vs guidance: Mixed

Did the claims hold up?

Management's claims vs. the numbers

H1 revenue growth 30.4% YoY, beats guidance

MET

H1 revenue ₹370.2 Cr vs ₹283.9 Cr prior year = 30.4%. FY27 guidance 20-25%.

Q2 EBITDA margin 11.1%, within 12-14% guidance

MISS

Q2 EBITDA ₹20.8 Cr / ₹187.5 Cr revenue = 11.1%. Guidance range 12-14%. Below range.

₹30-40 Cr deferred revenue from Q2 monsoon/logistics delays

MET

Management cited shipment delays and monsoon disruptions. Specific deferral amount cited.

Order book ₹1,662 Cr as of Sept 30, 2026; pipeline ₹5,000 Cr

OVERSTATED

No external validation in call; consistent with prior ₹1,801 Cr guidance. Pipeline increased from ₹6,000 Cr (prior guidance) to ₹5,000 Cr stated.

Large international orders: ₹500 Cr Nigeria (JNK Global), ₹830 Cr domestic flares

MET

Nigeria ₹500 Cr declared to stock exchange; domestic ₹830 Cr also claimed. Order book now includes these.

Earnings quality

What changed since the last call

Deltas vs. the prior call

Bidding pipeline revised downward

Downgrade

Prior guidance ₹6,000 Cr; now stated as ₹5,000 Cr. No explanation given. Narrows growth base.

Large Nigeria order secured

Upgrade

₹500 Cr Nigeria refinery heater package from JNK Global (repeat customer). Adds near-term visibility.

EBITDA margin guidance reaffirmed despite H1 miss

Neutral

H1 EBITDA 10.6% vs 12-14% guidance. Management reaffirmed FY27 guidance, betting on margin recovery in H2.

Execution challenges cited for Q2

Downgrade

Monsoon, logistics delays caused ₹30-40 Cr Q2 deferral. Shifts execution risk to H2.

The Q&A

Analysts pressed hard on deferral specifics (₹30-40 Cr), Dangote scope uncertainty, and non-heater pipeline timing. Management defended via seasonality narrative (H2 historically 60-65% of revenue) and timeline hedges (2-3 month Kenya inquiries, 4-5 month Dangote finalization). CFO candid on execution challenges but firm on FY27 guidance.

The exchanges that mattered

Deferral quantum and recovery — Shubham Borade, ICICI Securities

Answered

H1 up 30% already; H2 traditionally 60-65% of revenue. ₹30-40 Cr deferred from Q2, executable in H2. Order book ₹1,662 Cr provides foundation.

H2 executability — Deepak Purswani, SVAN Investments

Partial

Supply order is ₹500 Cr declared. Balance scope exists per Dangote declaration; could be ₹300-600 Cr. Still under discussion, timeline 2-3 months for clarity.

Kenya refinery timing — Deepak Purswani, SVAN Investments

Answered

Inquiries expected in 2-3 months. Discussion with BPCL likely to start December; ordering 6-8 months post-FID approval. Not in ₹5,000 Cr pipeline yet.

Non-heater pipeline details — Kamlesh Jain, Lotus Asset Managers

Answered

₹2,500 Cr non-heater opportunities. ₹1,000 Cr already bid/under discussion; ₹1,500 Cr to be bid soon. Could finalize in next two quarters.

BPCL Vizag refinery — Rupesh Tatiya, Long Equity Partners

Answered

FID approval still pending. Tenders likely 6-8 months post-FID; ordering expected in 12 months. Not yet in ₹5,000 Cr pipeline.

Chemdist subsidiary growth — Rupesh Tatiya, Long Equity Partners

Partial

Chemdist order book ~₹20 Cr currently. Main focus is green hydrogen, green fuels, sustainable chemicals. These will take 2 years to materialize into larger projects.

Working capital and debt funding — Ram Modi, PL Capital

Partial

With customer payment terms and bank limits, should self-fund without additional debt. No specific plan yet needed.

Commodity price hedging — Ram Modi, PL Capital

Answered

Some contracts have price variation clauses (e.g., PSU contracts). For others, it's a business risk. Minimal hedging strategies in place.

Order disclosure range — Ram Modi, PL Capital

Partial

CFO acknowledged; will narrow range going forward. Currently, exact value depends on client confidentiality; ₹300-600 is the realistic range for now.

Guidance

Forward guidance and management's confidence

FY27 revenue growth 20-25% (reaffirmed)

Medium

H1 already at 30.4%; H2 deferred revenue ₹30-40 Cr boosts likelihood. But execution risk remains.

EBITDA margin 12-14% on operational revenue (reaffirmed)

Low

H1 actual 10.6%; Q2 at 11.1%. Below range. Input cost pressure cited; margin recovery bet on H2.

Risks the call surfaced

Ranked by how much they should concern a holder

Execution delay risk

Medium

Q2 suffered ₹30-40 Cr deferral from monsoon, logistics. H2 must absorb this + full planned revenue. Project-based model makes timing volatile.

Margin pressure

High

EBITDA margin 10.6% (H1) vs 12-14% guidance. Q2 at 11.1%. Cause not detailed; likely cost of raw materials (steel, copper, aluminum).

Pipeline conversion uncertainty

Medium

₹5,000 Cr pipeline (₹2,500 Cr non-heating) is a target, not committed. Non-heating projects (green hydrogen, sustainable fuels) on 2+ year development cycles. Conversion risk high.

Large contingent order scope uncertainty

Medium

Nigeria ₹500 Cr declared to stock exchange. Balance scope (~₹300-600 Cr additional) is 'under discussion' with 2-3 month timeline. Not in order book; no certainty on total value.

International market readiness

Low

Kenya refinery (Dangote) still in FID approval stage; inquiries expected 2-3 months. BPCL Vizag FID pending. Timelines uncertain; projects 12+ months away from ordering.

Management

Score 6/10. CEO confident on order book and pipeline; CFO more cautious on specifics. Acknowledged execution challenges in Q2 honestly. Hedged on Dangote balance scope ('under discussion') and Kenya timeline (2-3 months). Not fully transparent on margin miss drivers. H1 beat revenue guidance (30.4% vs 20-25%); missed EBITDA margin (10.6% vs 12-14%). Q2 execution derailed by monsoon/logistics (₹30-40 Cr deferral). Maintains FY27 guidance despite challenges, betting on H2 recovery.

What to watch next
  • 1 · Q3 FY27 (Oct-Dec 2026)

    ₹30-40 Cr deferred Q2 revenue expected to shift; H2 seasonally strong (60-65% of annual revenue traditionally)

  • 2 · Nov 20, 2026

    NTPC and ONGC bidding packages bid due; potential large domestic infrastructure orders

  • 3 · Dec 2026 onwards

    Kenya refinery inquiries expected (2-3 month timeline); Dangote Nigeria balance scope discussions (4-5 month finalization)

Management maintains FY27 guidance but faces execution credibility test in Q3-Q4.

Informational and educational content only. Not investment advice.